Dr. Yucai Wang is an Associate Professor of Medicine and Oncology at Mayo Clinic in Rochester, Minnesota, and a Consultant in the Division of Hematology. He specializes in lymphoma, chronic lymphocytic leukemia (CLL), and CAR Tcell therapy. Dr. Wang serves as Chair of the Mantle Cell Lymphoma (MCL) Working Group at the Mayo Clinic Comprehensive Cancer Center and co-chairs the Diffuse 3 Large B-Cell Lymphoma (DLBCL) Working Group within the Lymphoma Epidemiology of Outcomes (LEO) Consortium, as well as the Lymphoma Committee of Academic and Community Cancer Research United (ACCRU). He is a member of the ECOG Lymphoma Core Committee and is actively involved in the development of novel clinical trials. Dr. Wang’s research focuses on clinical trials of innovative therapies and translational genetic and immunologic studies in B-cell malignancies. He is the principal
investigator of multiple investigator-initiated trials and
serves as site principal investigator for numerous
multicenter studies. Dr. Wang collaborates extensively with
lymphoma investigators both nationally and internationally.
His research is supported by funding from Conquer Cancer,
the Lymphoma Research Foundation, the National Cancer
Institute, industry partners, and Mayo Clinic.